594 related articles for article (PubMed ID: 29565038)
1. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
Xu MY; Wong AHC
Acta Pharmacol Sin; 2018 May; 39(5):733-753. PubMed ID: 29565038
[TBL] [Abstract][Full Text] [Related]
2. mGlu
Maksymetz J; Byun NE; Luessen DJ; Li B; Barry RL; Gore JC; Niswender CM; Lindsley CW; Joffe ME; Conn PJ
Cell Rep; 2021 Nov; 37(5):109950. PubMed ID: 34731619
[TBL] [Abstract][Full Text] [Related]
3. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
[TBL] [Abstract][Full Text] [Related]
4. GABAergic Interneuron Differentiation in the Basal Forebrain Is Mediated through Direct Regulation of Glutamic Acid Decarboxylase Isoforms by
Le TN; Zhou QP; Cobos I; Zhang S; Zagozewski J; Japoni S; Vriend J; Parkinson T; Du G; Rubenstein JL; Eisenstat DD
J Neurosci; 2017 Sep; 37(36):8816-8829. PubMed ID: 28821666
[TBL] [Abstract][Full Text] [Related]
5. An Optogenetic Approach for Investigation of Excitatory and Inhibitory Network GABA Actions in Mice Expressing Channelrhodopsin-2 in GABAergic Neurons.
Valeeva G; Tressard T; Mukhtarov M; Baude A; Khazipov R
J Neurosci; 2016 Jun; 36(22):5961-73. PubMed ID: 27251618
[TBL] [Abstract][Full Text] [Related]
6. Alterations in cortical interneurons and cognitive function in schizophrenia.
Dienel SJ; Lewis DA
Neurobiol Dis; 2019 Nov; 131():104208. PubMed ID: 29936230
[TBL] [Abstract][Full Text] [Related]
7. Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.
Morishita H; Kundakovic M; Bicks L; Mitchell A; Akbarian S
Neurobiol Learn Mem; 2015 Oct; 124():104-10. PubMed ID: 25849095
[TBL] [Abstract][Full Text] [Related]
8. Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment.
Koh MT; Rosenzweig-Lipson S; Gallagher M
Neuropharmacology; 2013 Jan; 64(1):145-52. PubMed ID: 22732440
[TBL] [Abstract][Full Text] [Related]
9. Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.
Nguyen R; Morrissey MD; Mahadevan V; Cajanding JD; Woodin MA; Yeomans JS; Takehara-Nishiuchi K; Kim JC
J Neurosci; 2014 Nov; 34(45):14948-60. PubMed ID: 25378161
[TBL] [Abstract][Full Text] [Related]
10. Glutamate- and GABA-based CNS therapeutics.
Foster AC; Kemp JA
Curr Opin Pharmacol; 2006 Feb; 6(1):7-17. PubMed ID: 16377242
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia.
Alshammari TK; Alshammari MA; Nenov MN; Hoxha E; Cambiaghi M; Marcinno A; James TF; Singh P; Labate D; Li J; Meltzer HY; Sacchetti B; Tempia F; Laezza F
Transl Psychiatry; 2016 May; 6(5):e806. PubMed ID: 27163207
[TBL] [Abstract][Full Text] [Related]
12. Regulation of intermittent oscillatory activity of pyramidal cell neurons by GABA inhibitory interneurons is impaired in schizophrenia: rationale for pharmacotherapeutic GABAergic interventions.
Deutsch SI; Rosse RB; Schwartz BL; Mastropaolo J; Burket JA; Weizman A
Isr J Psychiatry Relat Sci; 2010; 47(1):17-26. PubMed ID: 20686196
[TBL] [Abstract][Full Text] [Related]
13. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
Lewis DA; Volk DW; Hashimoto T
Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
[TBL] [Abstract][Full Text] [Related]
14. gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia.
Schwartz-Bloom RD; Sah R
J Neurochem; 2001 Apr; 77(2):353-71. PubMed ID: 11299298
[TBL] [Abstract][Full Text] [Related]
15. Use-dependent shift from inhibitory to excitatory GABAA receptor action in SP-O interneurons in the rat hippocampal CA3 area.
Lamsa K; Taira T
J Neurophysiol; 2003 Sep; 90(3):1983-95. PubMed ID: 12750426
[TBL] [Abstract][Full Text] [Related]
16. A GABAergic cortical deficit dominates schizophrenia pathophysiology.
Costa E; Davis JM; Dong E; Grayson DR; Guidotti A; Tremolizzo L; Veldic M
Crit Rev Neurobiol; 2004; 16(1-2):1-23. PubMed ID: 15581395
[TBL] [Abstract][Full Text] [Related]
17. Postnatal maturation of GABA(A) and GABA(C) receptor function in the mammalian superior colliculus.
Boller M; Schmidt M
Eur J Neurosci; 2001 Oct; 14(8):1185-93. PubMed ID: 11703447
[TBL] [Abstract][Full Text] [Related]
18. [Schizophrenia and cortical GABA neurotransmission].
Hashimoto T; Matsubara T; Lewis DA
Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
[TBL] [Abstract][Full Text] [Related]
19. GABAergic Interneuron and Neurotransmission Are mTOR-Dependently Disturbed in Experimental Focal Cortical Dysplasia.
Zhong S; Zhao Z; Xie W; Cai Y; Zhang Y; Ding J; Wang X
Mol Neurobiol; 2021 Jan; 58(1):156-169. PubMed ID: 32909150
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives.
Fee C; Banasr M; Sibille E
Biol Psychiatry; 2017 Oct; 82(8):549-559. PubMed ID: 28697889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
